Abstract: The invention provides methods and compositions for the repair or regeneration of osteochondral tissue. The methods and compositions provide an effective amount of isolated differentiable human Very Small Embryonic Like Stem Cells (hVSELs) sufficient for regeneration or repair of an osteochondral tissue. The compositions can be administered directly to the tissue or administered systemically.
Type:
Application
Filed:
April 9, 2012
Publication date:
April 24, 2014
Applicants:
NEOSTEM, INC., THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Inventors:
Russell Taichman, Paul H. Krebsbach, Aaron Havens, Anjali Mishra, Denis Rodgerson, Jingcheng Wang, Yusuke Shiozawa, Younghun Jung
Abstract: This application relates to stem cell compositions and methods for restoring age-related tissue loss in the face and other selected areas of the body. In a first embodiment, a composition includes stem cells and hyaluronic acid as a carrier wherein the stem cells are peripheral blood stem cells, bone marrow-derived blood stem cells, or mesenchymal stem cells.
Abstract: Provided herein are compositions and methods using stem/progenitor cells in a therapeutic approach for treatment of or promotion of healing of acute and chronic wounds.
Abstract: An elective healthcare insurance model using an individual's own peripheral blood stem cells for the individual's future healthcare uses. An individual can elect to have his or her own stem cells collected, processed and preserved, while he or she is in healthy or “pre-disease” state, for future distribution for his or her healthcare needs. The process includes methods of collection, processing, preservation and distribution of adult (including pediatric) peripheral blood stem cells during non-diseased state. The stem cells collected will contain adequate dosage amounts, for one or more transplantations immediately when needed by the individual for future healthcare treatments. The collected adult or non-neonate child peripheral blood stem cells can be aliquoted into defined dosage fractions before cryopreservation so that cells can be withdrawn from storage without the necessity of thawing all of the collected cells.
Type:
Application
Filed:
May 7, 2010
Publication date:
September 2, 2010
Applicant:
NEOSTEM, INC.
Inventors:
Thomas Gordon HIROSE, Simon Sun-man Lam, Rubio R. Punzalan, Denis O. Rodgerson
Abstract: An elective healthcare insurance model using an individual's own peripheral blood stem cells for the individual's future healthcare uses. An individual can elect to have his or her own stem cells collected, processed and preserved, while he or she is in healthy or “pre-disease” state, for future distribution for his or her healthcare needs. The process includes methods of collection, processing, preservation and distribution of adult (including pediatric) peripheral blood stem cells during non-diseased state. The stem cells collected will contain adequate dosage amounts, for one or more transplantations immediately when needed by the individual for future healthcare treatments. The collected adult or non-neonate child peripheral blood stem cells can be aliquoted into defined dosage fractions before cryopreservation so that cells can be withdrawn from storage without the necessity of thawing all of the collected cells.
Type:
Application
Filed:
March 30, 2006
Publication date:
October 19, 2006
Applicant:
NEOSTEM, Inc.
Inventors:
Thomas Hirose, Simon Lam, Rubio Punzalan, Denis Rodgerson